| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/20/2007 | US7192915 Methods for treating multiple sclerosis with GGF-related polypeptides |
| 03/20/2007 | US7192773 Gene expression; transforming nucleic acid; antiepileptic agents; antiarrhythmia agent |
| 03/20/2007 | US7192767 Matrix reactor and a method for producing products in said reactor |
| 03/20/2007 | US7192766 Sensor containing molded solidified protein |
| 03/20/2007 | US7192764 Cell surface layer-binding protein and utilization thereof |
| 03/20/2007 | US7192749 Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum |
| 03/20/2007 | US7192748 Isolated polynucleotides encoding phosphohexuloisomerase from Methylophilus methylotrophus |
| 03/20/2007 | US7192741 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 03/20/2007 | US7192740 Recombinant viral nucleic acids |
| 03/20/2007 | US7192739 Ligand-dependent protein splicing |
| 03/20/2007 | US7192738 IGF binding proteins |
| 03/20/2007 | US7192736 Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent |
| 03/20/2007 | US7192725 Flagellin gene, flaC of Campylobacter |
| 03/20/2007 | US7192723 useful as drugs for the prevention and treatment of various diseases, in terms of prolactin secretion inhibitors uch as pituitary tumor, diencephalon tumor, menstrual disorder, autoimmune diseases, prolactinoma, sterility, impotence |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192712 used as the internal standard in gene expression analysis |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192594 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/20/2007 | US7192593 Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| 03/20/2007 | US7192592 administering protein comprising a first polypeptide disulfide-bonded to a second polpeptide, wherein each of said first and second polypeptides comprises amino acid residues 258 to 370 of SEQ ID NO:2 and wherein said protein is mitogenic or chemotactic for mesenchymal cells |
| 03/20/2007 | US7192590 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192587 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/20/2007 | US7192584 Therapy of psoriasis in a human comprising administering human necrosis factor (TNF)-inhibiting amount of an anti-TNF antibody, wherein anti-TNF antibody competitively inhibits binding of TNF to monoclonal antibody cA2 |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192579 Retina specific; drug screening; for treating age-related macular degeneration |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | US7192576 neurotrophic activity; expression vector; facilitates proliferation, differentiation and/or survival of a cell |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/20/2007 | CA2281898C Promiscuous g-protein compositions and their use |
| 03/20/2007 | CA2256696C Modified small rna viruses |
| 03/20/2007 | CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/20/2007 | CA2204266C Purified papillomavirus proteins |
| 03/20/2007 | CA2182116C Cd 69 transcriptional regulatory elements |
| 03/20/2007 | CA2180954C Inhibitors of human plasmin derived from the kunitz domains |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/19/2007 | WO2008008082A2 Clostridial toxin activatable clostridial toxins |
| 03/19/2007 | CA2610103A1 Clostridial toxin activatable clostridial toxins |
| 03/15/2007 | WO2007030834A1 Chimeric hcn channels |
| 03/15/2007 | WO2007030706A1 Fragments of the glucagon-like peptide-i and uses thereof |
| 03/15/2007 | WO2007030637A2 Hiv gp120 crystal structure and its use to identify immunogens |
| 03/15/2007 | WO2007030573A2 Polypeptides useful for molecular weight determinations |
| 03/15/2007 | WO2007030519A2 Stabilized glp-1 analogs |
| 03/15/2007 | WO2007030518A2 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 03/15/2007 | WO2007030451A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 03/15/2007 | WO2007030244A2 An ultra-high yield intravenous immune globulin preparation |
| 03/15/2007 | WO2007030071A1 An isolated aquaporin in its closed conformation |
| 03/15/2007 | WO2007030012A2 Extracellular matrix imaging |
| 03/15/2007 | WO2007030001A1 A transgenic plant having enhanced drought tolerance |
| 03/15/2007 | WO2007029955A1 A new gene related to stresses and a method for producing a stress-resistant plant using the same |
| 03/15/2007 | WO2007029778A1 Hla-binding peptide, dna fragment encoding the peptide, and recombinant vector |
| 03/15/2007 | WO2007029484A1 Lactoferrin complex and method of producing the same |
| 03/15/2007 | WO2007029415A1 Protein constituting voltage-activated proton channel and use thereof |
| 03/15/2007 | WO2007029054A1 Immunoglobulin comprising predominantly a man7glcnac2, man8glcnac2 glycoform |
| 03/15/2007 | WO2007028983A1 Protein assay |
| 03/15/2007 | WO2007028969A2 Anchoring disruption molecules |
| 03/15/2007 | WO2007028636A1 Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |
| 03/15/2007 | WO2007028632A2 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 03/15/2007 | WO2007028631A1 Genetic risk factor for neurodevelopmental disorders and their complications |
| 03/15/2007 | WO2007028602A1 Novel gene sms 37 |
| 03/15/2007 | WO2007028574A2 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules |
| 03/15/2007 | WO2007028573A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 03/15/2007 | WO2007028244A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 03/15/2007 | WO2007028219A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti- hiv-i prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 03/15/2007 | WO2007028212A1 Noggin and chimeric molecules thereof |
| 03/15/2007 | WO2007008527A3 Chimeric vaccine for haemophilus influenzae-induced disease |
| 03/15/2007 | WO2007000675A3 Recombinant trimeric 4-1bbl |
| 03/15/2007 | WO2006128444A3 Autoactivated resistance protein |
| 03/15/2007 | WO2006127757A3 Interferon-igg fusion |
| 03/15/2007 | WO2006127284A3 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 03/15/2007 | WO2006126025A3 Cytokine |
| 03/15/2007 | WO2006123157A3 Nematistatic protein |
| 03/15/2007 | WO2006119897A3 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12 |
| 03/15/2007 | WO2006119013A3 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 03/15/2007 | WO2006117227A3 Solid phase bound thymosin alpha-1 and its synthesis |
| 03/15/2007 | WO2006116737A3 Compounds and methods for modulating cadherin-mediated processes |
| 03/15/2007 | WO2006114286A9 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis |
| 03/15/2007 | WO2006109196A3 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics |
| 03/15/2007 | WO2006103429A3 High affinity hiv t cell receptors |
| 03/15/2007 | WO2006099590A3 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 03/15/2007 | WO2006091233A3 Cellular delivery of reagents that inhibit gene expression utilizing the anthrax toxin protective antigen (pa) |
| 03/15/2007 | WO2006068481A3 Novel necrosis and ethylene inducing proteins from botrytis |
| 03/15/2007 | WO2006061853A3 Novel erythropoietic compounds and a process for producing erythropoietic compounds |
| 03/15/2007 | WO2006032708A3 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 03/15/2007 | WO2006021942A3 Platelet modulating oligopeptides |
| 03/15/2007 | WO2006021874A8 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/15/2007 | WO2006015214A3 Umbilical cord stem cell composition & method of treating neurological diseases |
| 03/15/2007 | WO2005007831A3 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 03/15/2007 | WO2004103295A3 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 03/15/2007 | WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide |
| 03/15/2007 | WO2003093432A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070061923 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/15/2007 | US20070061919 Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use |
| 03/15/2007 | US20070061916 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 03/15/2007 | US20070061911 Polynucleotides and polypeptides in plants |